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Overgrowth Syndromes and the Regulation of Signaling Complexes by
Proteoglycans
Scott B. Selleck
Department of Molecular and Cellular Biology, Division of Neurobiology, University of Arizona, Tucson
The charm of genetics, along with much of its power,
lies in its capacity to reveal connections that could never
have been anticipated. Pilia et al. (1996) must have been
surprised when they uncovered the gene responsible
for the overgrowth and tumor-susceptibility syndrome
Simpson-Golabi-Behmel syndrome (SGBS). SGBS is an
X-linked disorder characterized by pre- and postnatal
overgrowth; numerous morphological abnormalities, in-
cluding congenital heart defects; dysplastic kidneys; ver-
tebral and rib defects; and postaxial hexadactyly. In ad-
dition, patients are at high risk for Wilms tumor and
neuroblastoma (Neri et al. 1998). SGBS is caused by
disruptions of the glypican 3 gene (GPC3), which, re-
markably, encodes a proteoglycan of the glypican family.
The developmental abnormalities associated with SGBS
demonstrate that cell-surface proteoglycans can affect
tissue growth and morphogenesis and may serve as a
novel class of tumor suppressors.
How a proteoglycan affects growth regulation and
tumor susceptibility is not immediately obvious, but sev-
eral laboratories, including my own at the University of
Arizona, have found clues at the intersection of cell bi-
ology, biochemistry, and genetics. As is often the case,
an understanding of a human disease derives in large
measure from studies of different organisms and exper-
imental systems. The story that emerges highlights two
fundamental features of cell surfaces. First, the plasma
membrane is carpeted with sugars, principally as oli-
gosaccharides attached to lipids and proteins. Second,
the sugars found on the cell surface show a great deal
of structural diversity, with different forms represented
in tissue-specific patterns. The function of glycosylation
of cell-surface molecules has long been uncertain, but it
now appears that one class of sugar-modified proteins,
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the proteoglycans, influence interactions between other
molecules. Moreover, signaling-complex assembly may
be regulated, in part, by the interaction of ligands and
receptors with the sugar moieties of proteoglycans. It
therefore is likely that the different sugar structures
found on the cell surface provide the capacity to control
the assembly of many varied signaling complexes.
The Players
Proteoglycans are one class of sugar-modified mole-
cules on the cell surface, bearing glycosaminoglycan
(GAG) chains attached to serine residues framed within
a short “glycanation” acceptor site (SGXG, typically
with acidic amino acids on one or both sides; fig. 1)
(Esko and Zhang 1996). GAG chains are long, linear
polymers of disaccharide units. Unlike certain other clas-
ses of proteoglycans, glypicans bear one type of GAG
exclusively, namely, heparan sulfate (HS). HS, one of the
most prevalent types of GAG found on the cell surface,
is synthesized as a repeating polymer of glucuronic acid
and N-acetylglucosamine. Heparin, a highly sulfated
form of HS, is a potent anticoagulant and is naturally
found in mast-cell secretory granules. HS is ubiquitous,
occurring on cell surfaces and in the extracellularmatrix.
Heparin and HS are both synthesized as components of
proteoglycans: heparin is attached to the core protein
serglycin, whereas HS is attached to a diverse group of
core proteins.
HS is not a unique structure but a collection of related
molecules (Salmivirta et al. 1996) with different patterns
of sulfation, as well as other modifications that take
place after the disaccharide polymer is made (fig. 1).
These structural variants are found in tissue-specific dis-
tributions and show age- and disease-related changes
(Maccarana et al. 1996; Feyzi et al. 1998). Different HS
forms can be found attached to the same protein core
in different cell types and can influence the proteogly-
can’s biological properties (Sanderson et al. 1994).
Proteoglycans are most often thought of as extracel-
lular-matrix components, but some, like those of the
glypican family, are integral membrane proteins attached
to the plasma membrane via a glycosyl-phosphatidyli-
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Figure 1 Organization of glypicans. The polypeptide chain of glypicans is completely extracellular, with numerous disulfide bridges
producing a highly compact globular domain. GAG chains of the HS type are attached to serine residues near the carboxy terminus, via a
carbohydrate linker (in italics). The protein is covalently linked to the plasma membrane at its carboxy terminus, via a GPI attachment. HS is
a linear polymer of disaccharide units. A, Unmodified unit. B, Sulfated form of HS that usually represents !10% of all disaccharide units in a
chain. GlcNAc  N acetyl glucosamine; GlcA  glucuronic acid; Gal  galactose; Xyl  xylose; Man  mannose; GlcN  glucosamine; Ins
 inositol; IdoA  iduronic acid; P  phosphate.
nositol (GPI) linkage (Lander et al. 1996). At present,
five distinct glypican genes have been described in ver-
tebrates and one inDrosophila. GPC3 is responsible for
SGBS, and a Drosophila glypican, division abnormally
delayed (dally), affects both cell-division patterning and
morphogenesis during development (Nakato et al.
1995). All the glypicans share considerable sequence ho-
mology, including a set of 14 cysteine residues at con-
served positions, and sites of GAG attachment near the
carboxy terminus, where the protein bears the GPI link-
age (fig. 1).
Cell-Surface Proteoglycans and the Assembly of
Signaling Complexes
The phenotypes of SGBS patients, as well as those
that I and my colleagues have characterized in dallymu-
tant flies, raise the question of how a cell-surface pro-
teoglycan affects cellular physiology. A great deal of
evidence indicates that GAG chains are critical for
proteoglycan function. HS is a negatively charged mol-
ecule that binds a variety of extracellular proteins, in-
cluding growth factors. Landmark studies in the early
1990s showed that cell-surface HS is a required com-
ponent for fibroblast growth factor (FGF) signaling in
tissue-culture cells (Rapraeger et al. 1991; Olwin and
Rapraeger 1992). Cells with functional FGF receptors
(FGFRs) are incapable of FGF signaling if HS is enzy-
matically removed or its synthesis blocked by treatment
with chlorate.
These findings lead to the proposal that HS-modified
proteoglycans (HSPGs) serve as growth-factor corecep-
tors, which affect the delivery or assembly of ligands
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Figure 2 Effects on signaling, by cell-surface proteoglycans. A, Proteoglycans as growth-factor coreceptors. FGF binds to specific sequences
within an HS polymer, bringing together one or more FGF molecules. In addition, the FGFR recognizes HS, promoting assembly of the
proteoglycan-FGF-FGFR complex. B, Proteoglycans as allosteric regulators. Heparin (“Hep”) or HS can affect the conformation of AT, inducing
a conformational change so that it binds the protease factor Xa (“Xa”), producing an inactive AT-Xa complex. C, Proteoglycans as bridging
molecules. Heparin or HS can promote the association of AT with thrombin when both of these proteins bind the same heparin/HS chain.
Their rate of association is accelerated by their proximity on the heparin/HS chain.
into signaling complexes. The prevailing view holds that
HSPGs are important in the dimerization of FGF, which
in turn is required for receptor dimerization and sig-
naling. By addition of a twist to this model, there is
evidence that an HS-binding domain on the FGFR itself
is also required for signaling, suggesting that HSPGs
promote FGF and FGFR association by bringing them
into close proximity (fig. 2; also see Rapraeger 1995).
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Although FGF is the prototype among growth factors
that are affected by HSPGs, it is not unique. The activity
of other growth factors—including wingless (Wg), a
Drosophila Wnt (Reichsman et al. 1996), transforming
growth factor–b (TGF-b) (Lopez-Casillas et al. 1993),
hepatocyte growth factor (Zioncheck et al. 1995), and
heparin-binding epidermal growth factor (Aviezer and
Yayon 1994)—have all been shown to be affected by
the presence of cell-surface HS. In addition, vascular
endothelial growth factor, interleukin-3, granulocyte
macrophage colony–stimulating factor, and interferon-
g all bind HSPGs, raising the possibility that a very large
number of protein factors are influenced by the expres-
sion and structure of proteoglycans (Nelson et al. 1995).
However, evidence that proteoglycans act in growth-
factor–signaling pathways during development comes
largely from studies of the fruit fly.
In Vivo Studies of Dally, a Fly Glypican
Many biochemical and tissue-culture studies support
the hypothesis that cell-surface proteoglycans, likeGPC3
in humans, affect growth-factor signaling during devel-
opment. It is not yet known whether defects in growth-
factor–signaling pathways account for the abnormalities
in SGBS patients, but tools to address this question have
recently become available for the mouse.Gpc3 knockout
mice have been described, and these mice show many
of the defects found in SGBS patients, including gener-
alized overgrowth (J. Filmus, personal communication).
We therefore can look forward to more-detailed studies
of the molecular and cellular abnormalities that follow
from GPC3 dysfunction.
At present, the best evidence of a role for glypicans
in growth-factor signaling during development derives
from work with two secreted, heparin/HS-binding
growth factors that play key roles in Drosophila devel-
opmental patterning: decapentaplegic (Dpp), a TGF-b
superfamily member most closely related to bone mor-
phogenetic protein (BMP)–2 and BMP-4, andWg, aWnt
family member. To test the hypothesis that mutations in
glypicans affect growth-factor signaling, my colleagues
and I began by examining whether phenotypes observed
in dally mutants were a consequence of compromised
Dpp function. A variety of experiments showed this to
be the case (Jackson et al. 1997). For example, dally
mutants show defects in the activation of known Dpp
target genes, without affecting the expression of Dpp,
and reduction in Dpp function greatly increases the se-
verity of dally phenotypes. Similarly, overgrowth defects
produced by misexpression of Dpp can be rescued by
reducing dally function, which supports the argument
that dally serves to influence cellular responses to Dpp.
Our studies showed that dally works, at least in part,
by affecting the function of Dpp.
In addition to their effects on Dpp (and, by extension,
other TGF-b family members), proteoglycans are also
implicated in Wnt signaling. Genetic screens for muta-
tions affecting Wg signaling in Drosophila suggest that
this growth factor also requires GAG biosynthesis for
its normal function during embryonic development.
Three laboratories identified mutations in a Drosophila
gene encoding a protein with homology to UDP-glucose
dehydrogenase (dUDPG-DH, known as sugarless, sup-
penkasper, or kiwi) (Binari et al. 1997; Ha¨cker et al.
1997; Haerry et al. 1997). UDPG-DH is required for
the synthesis of UDP-glucuronate. Glucuronate is one of
the two backbone sugars of HS, and UDP-glucuronate
serves as the nucleotide sugar donor. Mutations in Dro-
sophila UDPG-DH disrupt Wg signaling in the early em-
bryo and are lethal. Interestingly, overexpression of Wg
can compensate for the loss of UDPG-DH, suggesting
that HSPGs serve to enhance the signaling activity of
Wg but are not sine qua non components of the receptor
(Ha¨cker et al. 1997). Our experiments, in collaboration
with Hiroshi Nakato’s group, indicate that dally influ-
ences Wg signaling during embryonic development (M.
Tsuda and S. B. Selleck, unpublished data). These find-
ings suggest that dally serves as a component of the Wg
receptor, influencing the assembly of an active signaling
complex. Our studies also indicate that dally is not sim-
ply a general enhancer of growth-factor signaling but
participates selectively in either Dpp or Wg signaling, in
a tissue-specific manner.
Polysaccharide Structure and Tissue Patterning
We have hypothesized that different sugar modifica-
tions of Dally might govern its participation in different
growth-factor–signaling assemblies. Two recent genetic
studies lend credence to this idea and suggest that sul-
fation of HS is one such biologically relevant sugar mod-
ification required for discrete patterning events during
development. First, a gene trap–induced mutation in a
gene encoding an HS-modifying enzyme, HS-2-sulfo-
transferase (HS-2st), produces renal agenesis as well as
eye and skeletal abnormalities (Kobayashi et al. 1997;
Bullock et al. 1998). HS-2st shows tissue-specific pat-
terns of expression, and, because 2-O-sulfation can af-
fect the interaction with HS of growth-factor ligands, it
seems likely that tissue-specific modifications of HS reg-
ulate HSPG growth-factor assemblies in the mouse.
More direct evidence of a role for 2-O-sulfotransferase
activity in patterning comes from studies of genes con-
trolling axis formation inDrosophila.The dorsal-ventral
axis of the embryo begins to be established before fer-
tilization and requires the follicle cells that surround the
oocyte (reviewed in Anderson 1998). In the absence of
normal follicle-cell function, embryos are “dorsalized”
and completely lack ventral structures. A critical role
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served by these follicle cells is the activation of the ven-
tralizing signal, that is, the secreted protein Spa¨tzle. This
activation is restricted to the ventral region of the de-
veloping embryo and depends on the expression in the
follicle cells of the gene pipe, which encodes a protein
homologous to vertebrate 2-O-sulfotransferase (Sen et
al. 1998). Ectopic pipe expression is sufficient to ven-
tralize dorsal cells, suggesting that localized 2-O-sulfa-
tion of an HSPG is critical to the activation of the ven-
tralizing signal provided by Spa¨tzle.
Several other genes required, in follicle cells, for Spa¨t-
zle activation encode secreted proteases, and protease
activity has been shown to be critical for the generation
of ventral structures. The homology of pipe to a verte-
brate 2-O-sulfotransferase suggests that a proteoglycan
may be required for the proteolytic processing of Spa¨tzle.
Perhaps, for example, a 2-O-sulfated HSPG forms a
docking site for the proteolytic activation of Spa¨tzle.
Although one must acknowledge the caveat that pipe
has not yet been shown to act as a 2-O-sulfotransferase,
these findings emphasize that HS-modifying enzymes
and their proteoglycan substrates are likely to play crit-
ical roles in spatially regulated signaling events during
development.
Molecular Models for HSPG Functions in SGBS
The genetic studies of mice and flies show that pro-
teoglycans and HS biosynthetic and modifying enzymes
affect patterning during development. The activities of
these genes are expressed at least in part by their influ-
ence on the signaling of two key secreted growth-factor
families, the Wnts and the TGF-b/BMPs. However, what
precisely are HSPGs doing at the cell surface, and how
might they affect signaling there? One model, referred
to above, maintains that HSPGs serve as growth-factor
coreceptors by helping to deliver ligands to the signaling
receptor. However, HSPGs might also affect molecular
assemblies at the cell surface by other means, and there
is experimental support for two other mechanisms: (1)
HS as an allosteric regulator changing the conformation
of proteins that bind to specific HS sequences and (2)
HSPGs as “molecules of encounter” facilitating the in-
teraction between two other components. As shown in
figure 2, both these mechanisms play a role in the reg-
ulation, by HS, of blood coagulation on the luminal
surface of endothelial cells (Rosenberg et al. 1997). The
serine protease inhibitor antithrombin (AT) inactivates
the proteases thrombin and factor Xa as a means of
regulating the coagulation cascade. Heparin—a highly
sulfated form of HS—accelerates AT-protease interac-
tions by two different mechanisms. First, heparin bind-
ing to AT induces conformational changes that accel-
erate AT-Xa–complex generation. Second, both AT and
thrombin bind to one long-chain heparin molecule, pro-
moting AT-thrombin association. The regulation of pro-
teases by HSPGs might provide a paradigm for under-
standing how pipe controls dorsal-ventral patterning
during Drosophila development.
These models provide a basis for the understanding
of how loss of GPC3 might cause the overgrowth, pat-
terning defects, and tumor susceptibility that character-
ize SGBS. It has been suggested that GPC3 binds to
insulin-like growth factor–2 (IGF2) and that loss of
GPC3 might increase the levels of IGF2, hence promot-
ing tissue growth. However, rat Gpc3 does not bind to
IGF2, which casts some doubt on this model (Song et
al. 1997), although it is possible that GPC3 affects IGF2
activity indirectly, perhaps by regulating IGF2-binding
proteins. It seems very unlikely, however, that all the
phenotypes associated with SBGS will be accounted for
by defects in IFG2 activity alone. The evidence from
Drosophila and from cell-culture systems suggests that
many different growth factors are likely to be affected
by loss of GPC3. Clearly,Wnt and TGF-b/BMP signaling
could be compromised in SGBS patients. TGF-b is a well-
known inhibitor of cell-cycle progression, and the loss
of GPC3 could compromise TGF-b–mediated control of
cell division. Disruptions in TGF-b–signaling compo-
nents, including the Smads, and in TGF-b receptors are
associated with tumor progression (Moskaluk and Kern
1996), suggesting that the neoplasia associated with
SBGS could reflect a loss of normal TGF-b activity.
Recently, mouse Gpc3 has been shown to affect apop-
tosis in different tissue-culture cell lines (Gonzalez et al.
1998). Perhaps some of the phenotypes of SGBS pa-
tients, such as hexadactyly, are the consequence of de-
fects in programmed cell death during development. In
this regard, it is interesting to note that TGF-b/BMPs
have been implicated in the induction of programmed
cell death during limb morphogenesis (Merino et al.
1998). In sum, the many SGBS phenotypes found prob-
ably reflect the variety of signaling events that are af-
fected by loss of this cell-surface proteoglycan. The anal-
ysis of proteoglycans will yield a great deal of insight
into the molecular topography of the cell surface and
the orchestration of signaling events that take place
there.
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